Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Dave Jones
Dec 21, 2021 5:50AM ET
Do you read the comments Peter Nurse?
0
0
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
💎 Reveal Undervalued Stocks Hiding in Any Market Get Started
European Stocks Higher; Moderna Vaccine News Helps Sentiment
© Reuters.
By Peter Nurse
Investing.com - European stock markets traded higher Tuesday, rebounding after the previous session’s hefty losses, but concerns about the risks associated with the Omicron Covid-19 variant remain.
At 3:55 AM ET (0855 GMT), the DAX in Germany traded 0.7% higher, the CAC 40 in France rose 0.8% and the U.K.’s FTSE 100 climbed 1%.
Helping the tone Tuesday was the news from Moderna (NASDAQ:MRNA) that the U.S. drugmaker could develop a booster shot to protect against the Omicron variant in a relatively short period.
"It only needs minor adjustments for Omicron. I don't expect any problems," CEO Stephane Bancel said in an interview with the Swiss newspaper TagesAnzeiger published on Tuesday.
The European Union has also approved the use of Novavax 's (NASDAQ:NVAX) vaccine in people aged 18 or over, making it the fifth shot available for use within the bloc.
European equity indexes sold off sharply on Monday, with the DAX in Germany dropping almost 2%, after various countries in the region adopted restrictive measures to stop the spread of the virulent Omicron strain of the Covid-19 virus, including the Netherlands imposing a full lockdown of non-essential stores.
New Zealand delayed the planned reopening of its international border on Tuesday because of the sweeping spread of Omicron around the world, the U.S. advised its citizens against travel to eight destinations, including Spain and Finland, and British Prime Minister Boris Johnson said he would tighten coronavirus curbs if needed but held off from actually doing so.
In corporate news, Sanofi (NASDAQ:SNY) stock fell 0.2% after the French drugmaker announced its intentions to buy Amunix Pharmaceuticals for an upfront payment of about $1 billion, marking the latest acquisition by the French drugmaker in the U.S. biotech sphere.
Additionally, Renault (PA:RENA) stock rose 1% after Reuters reported that the French carmaker is set to announce a joint venture with Geely Holding to jointly produce the Chinese automaker's hybrid vehicles in South Korea.
Turning to economic data, the latest GfK German consumer climate index slumped to -6.8 from -1.6 the previous month as the latest Covid restrictions dented confidence.
Oil prices rose Tuesday, rebounding after a couple of days of sharp selling, and investors now await U.S. crude oil supply data from the American Petroleum Institute, due later in the day.
By 3:55 AM ET, U.S. crude futures traded 0.6% higher at $69.05 a barrel, while the Brent contract rose 0.3% to $71.71.
Additionally, gold futures rose 0.2% to $1,797.35/oz, while EUR/USD climbed 0.2% higher to 1.1300.
Related Articles
Comments (3)
Speculeerbeer
Dec 21, 2021 5:50AM ET
Why would he? The comments here are 90% conspiracy nonsense.
0
0
Rcd72
Dec 21, 2021 5:35AM ET
PPI Italy rose to 20!!!!! %.....silly Ponzi liquidity going to lead all world to famine and war
3
0
Jack Hudson
Dec 21, 2021 5:35AM ET
Seems to be the plan. When all else fails........
0
0
Adi Avivi
Dec 21, 2021 5:13AM ET
it is not the omicron.. it is the intrest. not leaving my shorts :)
0
0
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.